The number of companies providing hub services continues to increase as they observe a growing opportunity in today’s market environment
XPOVIO, from Karyopharm Therapeutics, is the first and only prescription medicine approved in the U.S. for the treatment of multiple myeloma
McKesson Corporation announced a multi-year strategic growth initiative in 2018, focused on creating innovative new solutions that improve patient care delivery and drive incremental profit growth. The initiative comprises multiple growth pillars, and includes a comprehensive review of the company’s operations and cost structure, designed to increase efficiency, accelerate execution and improve long-term performance. McKesson’s […]